Cetera Investment Advisers
RNTX

Cetera Investment Advisers’s Rein Therapeutics RNTX Stock Holding History

Cetera Investment Advisers’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Buy
+11,742
New +$14.2K ﹤0.01% 4884
2026
Q1 		– Sell
-12,364
Closed -$14.3K – 4999
2025
Q4 		$14.3K Hold
12,364
– – ﹤0.01% 4596
2025
Q3 		$14.2K Sell
12,364
-1,282
-9% -$1.63K ﹤0.01% 4509
2025
Q2 		$19.1K Buy
+13,646
New +$24.6K ﹤0.01% 4027
2022
Q4 		– Sell
-1,312
Closed -$5K – 2176
2022
Q3 		$5K Buy
1,312
+437
+50% +$1.85K ﹤0.01% 1675
2022
Q2 		$5K Hold
875
– – ﹤0.01% 1808
2022
Q1 		$9K Sell
875
-42
-5% -$380 ﹤0.01% 1854
2021
Q4 		$10K Buy
+917
New +$14.2K ﹤0.01% 1846

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Cetera Investment Advisers's RNTX Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in Rein Therapeutics (RNTX) in Q2 2026: 11,742 shares worth $12.2K. The stake represents ﹤0.01% of the portfolio and ranks #4884 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in RNTX as recently as Q4 2025.

Cetera Investment Advisers first reported a position in RNTX in Q4 2021 and has held it in 8 quarters since. The position peaked at $19.1K in Q2 2025. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Cetera Investment Advisers held 11,742 shares of Rein Therapeutics worth $12.2K as of Q2 2026.
  • Rein Therapeutics was a new Cetera Investment Advisers position in Q2 2026.
  • Rein Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4884 holding.
  • Cetera Investment Advisers first reported a position in Rein Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • Cetera Investment Advisers's Rein Therapeutics position peaked at $19.1K in Q2 2025.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.